For over 50 years, Nasdaq has been a leader in the exchange space through our technology innovations. We built our IPO process in partnership with the investment banking community, ensuring that ...

Aardvark is only the latest biotech looking to squeeze through the slowly widening IPO window. This morning will also see Hong Kong-listed Ascentage try its luck on the Nasdaq via a $126.4 million ...